BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 20352235)

  • 1. Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
    Klaiber M; Kruse M; Völker K; Schröter J; Feil R; Freichel M; Gerling A; Feil S; Dietrich A; Londoño JE; Baba HA; Abramowitz J; Birnbaumer L; Penninger JM; Pongs O; Kuhn M
    Basic Res Cardiol; 2010 Sep; 105(5):583-95. PubMed ID: 20352235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
    Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
    Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice.
    Yurukova S; Kilić A; Völker K; Leineweber K; Dybkova N; Maier LS; Brodde OE; Kuhn M
    Cardiovasc Res; 2007 Mar; 73(4):678-88. PubMed ID: 17107670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide-mediated inhibition of microcirculatory endothelial Ca2+ and permeability response to histamine involves cGMP-dependent protein kinase I and TRPC6 channels.
    Chen W; Oberwinkler H; Werner F; Gaßner B; Nakagawa H; Feil R; Hofmann F; Schlossmann J; Dietrich A; Gudermann T; Nishida M; Del Galdo S; Wieland T; Kuhn M
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2121-9. PubMed ID: 23814119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I.
    Frantz S; Klaiber M; Baba HA; Oberwinkler H; Völker K; Gaβner B; Bayer B; Abeβer M; Schuh K; Feil R; Hofmann F; Kuhn M
    Eur Heart J; 2013 Apr; 34(16):1233-44. PubMed ID: 22199120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition.
    Nishida M; Watanabe K; Sato Y; Nakaya M; Kitajima N; Ide T; Inoue R; Kurose H
    J Biol Chem; 2010 Apr; 285(17):13244-53. PubMed ID: 20177073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger.
    Shah A; Gul R; Yuan K; Gao S; Oh YB; Kim UH; Kim SH
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1365-74. PubMed ID: 20190099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local actions of atrial natriuretic peptide counteract angiotensin II stimulated cardiac remodeling.
    Kilić A; Bubikat A; Gassner B; Baba HA; Kuhn M
    Endocrinology; 2007 Sep; 148(9):4162-9. PubMed ID: 17510245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
    Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cardiac pathway of cyclic GMP-independent signaling of guanylyl cyclase A, the receptor for atrial natriuretic peptide.
    Klaiber M; Dankworth B; Kruse M; Hartmann M; Nikolaev VO; Yang RB; Völker K; Gassner B; Oberwinkler H; Feil R; Freichel M; Groschner K; Skryabin BV; Frantz S; Birnbaumer L; Pongs O; Kuhn M
    Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18500-5. PubMed ID: 22027011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
    Onohara N; Nishida M; Inoue R; Kobayashi H; Sumimoto H; Sato Y; Mori Y; Nagao T; Kurose H
    EMBO J; 2006 Nov; 25(22):5305-16. PubMed ID: 17082763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
    Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
    J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperactive adverse mechanical stress responses in dystrophic heart are coupled to transient receptor potential canonical 6 and blocked by cGMP-protein kinase G modulation.
    Seo K; Rainer PP; Lee DI; Hao S; Bedja D; Birnbaumer L; Cingolani OH; Kass DA
    Circ Res; 2014 Feb; 114(5):823-32. PubMed ID: 24449818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
    Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
    Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGFB-VEGFR1 ameliorates Ang II-induced cardiomyocyte hypertrophy through Ca
    Shen Z; Zhang Z; Wang X; Yang K
    J Cell Biochem; 2018 Feb; 119(2):1511-1520. PubMed ID: 28771828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.
    Rosenkranz AC; Woods RL; Dusting GJ; Ritchie RH
    Cardiovasc Res; 2003 Feb; 57(2):515-22. PubMed ID: 12566124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cGMP-dependent protein kinase mediates stimulation of L-type calcium current by cGMP in rabbit atrial cells.
    Wang Y; Wagner MB; Joyner RW; Kumar R
    Cardiovasc Res; 2000 Nov; 48(2):310-22. PubMed ID: 11054477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy.
    Nunn C; Zou MX; Sobiesiak AJ; Roy AA; Kirshenbaum LA; Chidiac P
    Cell Signal; 2010 Aug; 22(8):1231-9. PubMed ID: 20362664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.